Aspen Aerogels (NYSE:ASPN) reported a significant financial contraction for fiscal year 2025 on Wednesday, prompting the company to initiate a formal strategic review to optimize its cost structure and evaluate its asset portfolio.
The Northborough, Massachusetts-based technology leader saw its annual revenue plummet 40% to $271.1 million, compared to $452.7 million in 2024, as a "reset" in the U.S. electric vehicle (EV) market severely curtailed demand for its thermal barrier products.
The company’s bottom line was hit by a massive $389.6 million net loss, or approximately $(4.73) per share.
The results were dominated by a $291.2 million non-cash impairment charge, primarily related to the decision to suspend construction of its second aerogel manufacturing facility in Statesboro, Georgia.
Fourth-quarter performance underscored the depth of the slowdown, with revenue falling 66% year-over-year to $41.3 million.
Despite the top-line pressure, Aspen generated $16.1 million in operating cash flow during the quarter and successfully cut more than $75 million from its fixed cost base.
The company ended the year with $158.6 million in cash and equivalents.
As part of its strategic review, conducted with advisor Piper Sandler, Aspen is exploring options to monetize its Statesboro assets and strengthen its balance sheet.
While management issued a cautious outlook for early 2026, projecting Q1 revenue between $35 million and $40 million, they highlighted a new EV award from Volvo Cars and a North Sea subsea project as catalysts for a potential second-half recovery.